Unknown

Dataset Information

Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications.


ABSTRACT:

Purpose of review

To highlight the added benefits of approved and upcoming, centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and cardiovascular effects but also on their less explored clinical benefits and drawbacks, in order to provide clinicians with a tool for more comprehensive, pharmacological management of obesity.

Recent findings

Obesity is increasingly prevalent worldwide and has become a challenge for healthcare systems and societies. Reduced life expectancy and cardiometabolic complications are some of the consequences of this complex disease. Recent insights into the pathophysiology of obesity have led to the development of several promising pharmacologic targets, so that even more effective drugs are on the horizon. The perspec

SUBMITTER: Guglielmi V 

PROVIDER: S-EPMC10250472 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature